Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancer.

Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancer.

Squamous cell lung carcinomas account for approximately 25% of new lung carcinoma cases and 40,000 deaths per year in the United States. Although there are multiple genomically targeted therapies for lung adenocarcinoma, none has yet been reported in squamous cell lung carcinoma.Using SNP array anal...

Full description

Bibliographic Details
Main Authors: Amit Dutt, Alex H Ramos, Peter S Hammerman, Craig Mermel, Jeonghee Cho, Tanaz Sharifnia, Ajit Chande, Kumiko Elisa Tanaka, Nicolas Stransky, Heidi Greulich, Nathanael S Gray, Matthew Meyerson
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2011-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3110189?pdf=render

Internet

http://europepmc.org/articles/PMC3110189?pdf=render

Similar Items